ABVC BioPharma, Inc. Debt Conversion, Converted Instrument, Amount
ABVC BioPharma, Inc. (ECOC) reported Debt Conversion, Converted Instrument, Amount of $563.82 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2026-08-12
- ABVC BioPharma, Inc. debt conversion, converted instrument, amount for the quarter ending 2025-12-31 was $0.00.
- ABVC BioPharma, Inc. debt conversion, converted instrument, amount for the quarter ending 2025-09-30 was $0.00.
- ABVC BioPharma, Inc. debt conversion, converted instrument, amount for the quarter ending 2025-06-30 was $0.00.
- ABVC BioPharma, Inc. debt conversion, converted instrument, amount for the quarter ending 2025-03-31 was $563.82K.
- ABVC BioPharma, Inc. debt conversion, converted instrument, amount for fiscal 2025 was $563.82K, a 6.03% decline from fiscal 2024.
- ABVC BioPharma, Inc. debt conversion, converted instrument, amount for fiscal 2024 was $600.00K.
- ABVC BioPharma, Inc. debt conversion, converted instrument, amount for fiscal 2021 was $2.69M, a 56.87% increase from fiscal 2020.
- ABVC BioPharma, Inc. debt conversion, converted instrument, amount for fiscal 2020 was $1.72M.
| Period end | Debt Conversion, Converted Instrument, Amount 1 month | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | $0.00 derived: sum of 2 quarters · filed 2026-03-03 | $0.00 derived: sum of 3 quarters · filed 2026-08-12 | $563.82K 10-K · filed 2026-03-03 | |
| 2025-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-03-03 | $0.00 derived: sum of 2 quarters · filed 2026-08-12 | $563.82K 10-Q/A · filed 2026-03-03 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $563.82K 10-Q · filed 2026-08-12 | |||
| 2025-03-31 | $563.82K 10-Q · filed 2026-05-18 | ||||
| 2024-12-31 | $600.00K 10-K · filed 2025-04-15 | ||||
| 2021-12-31 | -$2.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $2.69M 10-K · filed 2022-03-31 | |||
| 2021-09-30 | $2.69M 10-Q · filed 2021-11-15 | ||||
| 2020-12-31 | $270.27K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $1.72M 10-K · filed 2022-03-31 | |||
| 2020-09-30 | $1.45M 10-Q · filed 2021-11-15 | ||||
| 2019-08-31 | $4.87M 10-Q · filed 2022-11-14 |